Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01931644
Recruitment Status : Recruiting
First Posted : August 29, 2013
Last Update Posted : October 8, 2019
Sponsor:
Information provided by (Responsible Party):
Sanguine Biosciences

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

Condition or disease
All Diagnosed Health Conditions ADD/ADHD Alopecia Areata Ankylosing Spondylitis Asthma Atopic Dermatitis Eczema Beta Thalassemia Bipolar Disorder Breast Cancer Celiac Disease Cervical Cancer Chronic Inflammatory Demyelinating Polyneuropathy Chronic Kidney Diseases Chronic Obstructive Pulmonary Disease Colon Cancer Colorectal Cancer Crohn's Disease Cystic Fibrosis Depression Diabetes Mellitus Duchenne Muscular Dystrophy Endometriosis Epilepsy Facioscapulohumeral Muscular Dystrophy G6PD Deficiency General Anxiety Disorder Hepatitis B Hereditary Hemorrhagic Telangiectasia HIV/AIDS Human Papilloma Virus Huntington's Disease Idiopathic Thrombocytopenic Purpura Insomnia Kidney Cancer Leukemia Lung Cancer Lupus Nephritis Lymphoma Melanoma Multiple Myeloma Multiple Sclerosis Myositis Myotonic Dystrophy Ovarian Cancer Pancreatic Cancer Parkinson's Disease Polycystic Kidney Diseases Prostate Cancer Psoriasis Psoriatic Arthritis Rosacea Scleroderma Sickle Cell Anemia Sickle Cell Trait Sjogren's Syndrome Skin Cancer Spinal Muscular Atrophy Systemic Lupus Erythematosus Thrombotic Thrombocytopenic Purpura Trisomy 21 Ulcerative Colitis

Detailed Description:
This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 20000 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Study Start Date : July 2013
Estimated Primary Completion Date : August 2025
Estimated Study Completion Date : December 2040

Resource links provided by the National Library of Medicine

Genetic and Rare Diseases Information Center resources: Multiple Myeloma Lymphosarcoma Ovarian Cancer Pancreatic Cancer Renal Cell Carcinoma Immune Thrombocytopenia Idiopathic Thrombocytopenic Purpura Chronic Graft Versus Host Disease Sickle Cell Anemia Thalassemia Beta-thalassemia Cystic Fibrosis Muscular Dystrophy Becker Muscular Dystrophy Duchenne Muscular Dystrophy Idiopathic Inflammatory Myopathy Glucose-6-phosphate Dehydrogenase Deficiency Systemic Scleroderma Spinal Muscular Atrophy Ovarian Epithelial Cancer Chronic Inflammatory Demyelinating Polyneuropathy Myotonic Dystrophy Lupus Nephritis Chromosomal Triplication Huntington Disease Facioscapulohumeral Muscular Dystrophy Hereditary Hemorrhagic Telangiectasia Thrombotic Thrombocytopenic Purpura, Acquired Neuroendocrine Tumor Neuroepithelioma Spondylarthropathy Glomerulonephritis Amyotrophic Lateral Sclerosis

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Health Condition
Collect blood and other optional biospecimens from participants with a diagnosed health condition
Healthy Control
Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Biospecimen & Clinical Data Collection [ Time Frame: 10 years ]
    To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results


Biospecimen Retention:   Samples With DNA
Whole blood, serum, plasma, PBMC, RNA, DNA, saliva, stool, hair, skin, CSF, synovial fuid, tumor tissue, urine

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Diagnosed with a health condition
Criteria

Inclusion Criteria:

  • All adults 18-100 years old
  • Able to provide proof of diagnosis
  • Live in USA

Exclusion Criteria:

  • Younger than 18 years old
  • Receipt of blood products within 30 days of study blood collection
  • Receipt of investigational drug within 30 days of study blood collection
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01931644


Contacts
Layout table for location contacts
Contact: Carolyn Bidwell 855.836.4759 study@sanguinebio.com

Locations
Layout table for location information
United States, California
Sanguine Biosciences Recruiting
Los Angeles, California, United States, 91403
Contact: Carolyn Bidwell    855-836-4759    study@sanguinebio.com   
Principal Investigator: Houman Hemmati, MD         
Sponsors and Collaborators
Sanguine Biosciences
Investigators
Layout table for investigator information
Principal Investigator: Houman Hemmati, MD Sanguine Biosciences
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Sanguine Biosciences
ClinicalTrials.gov Identifier: NCT01931644    
Other Study ID Numbers: SAN-BB-01
First Posted: August 29, 2013    Key Record Dates
Last Update Posted: October 8, 2019
Last Verified: October 2019
Keywords provided by Sanguine Biosciences:
Idiopathic Thrombocytopenic Purpura
ADD/ADHD
Alopecia Areata
Ankylosing Spondylitis
Asthma
Atopic Dermatitis Eczema
Beta Thalassemia
Bipolar Disorder
Breast Cancer
Celiac Disease
Cervical Cancer
Chronic Inflammatory Demyelinating Polyneuropathy
Chronic Kidney Diseases
Chronic Obstructive Pulmonary Disease
Colon Cancer
 Colorectal Cancer
Crohn's Disease
Cystic Fibrosis
Depression
Diabete Mellitus
Duchenne Muscular Dystrophy
Endometriosis
Epilepsy
Facioscapulohumeral Muscular Dystrophy
G6PD Deficiency
General Anxiety Disorder
Hepatitis B
Hereditary Hemorrhagic Telangiectasia
HIV/AIDS
Human Papilloma Virus
Additional relevant MeSH terms:
Layout table for MeSH terms
Immune System Diseases
Thrombocytopenia
Hepatitis B
Spondylitis
Acquired Immunodeficiency Syndrome
HIV Infections
Prostatic Neoplasms
Colorectal Neoplasms
Melanoma
Multiple Myeloma
Pancreatic Neoplasms
Ovarian Neoplasms
Uterine Cervical Neoplasms
Colonic Neoplasms
Kidney Neoplasms
 Carcinoma, Renal Cell
Skin Neoplasms
Papilloma
Arthritis
Muscular Dystrophies
Arthritis, Psoriatic
Spondylarthritis
Muscular Dystrophy, Duchenne
Spondylitis, Ankylosing
Sjogren's Syndrome
Myositis
Myotonic Dystrophy
Muscular Dystrophy, Facioscapulohumeral
Hepatitis
Cystic Fibrosis